DSS Induced IBD Model

The dextran sulfate sodium (DSS)-induced IBD mouse model uses DSS (MW 36,000 - 50,000), a sulfated polysaccharide. Administering DSS to mice damages colonic epithelial cells, impairing mucosal barriers and leading to ulcerative colitis (UC) - like conditions. These mice show symptoms similar to those observed in human IBD patients, including weight loss, diarrhea, and fecal occult blood. Acute DSS colitis involves neutrophil and macrophage activation, with Th1, Th17, and Treg cells also participating. This model is useful for studying IBD pathogenesis and treatments.


DSS Induced Acute IBD Model


  • Acute UC model which resembles the histological changes in UC patients

  • Widely used and easy to establish

  • Short experiment period and relatively low cost


1.jpeg


Modeling strategy: C57BL/6JGpt, male; DSS induced

Validation data: DSS-induced IBD model for efficacy evaluation of cyclosporine A


2.jpeg


The treatment with cyclosporine A ameliorated the DAI score, increased the colon length and decreased the HE score in IBD models induced by DSS.


DSS-induced chronic colitis model


Experimental mouse strains: B6, 6-7weeks old, male

Modeling cell: 3% DSS

Modeling method:


3.jpeg



4.jpeg

Body weight-loss and DAI score increase were observed in DSS induced model.

 

5.jpeg

Mesenteric lymph node (mLN) weight increase was observed in DSS induced model.


8.jpeg

Colon weight increase and length decrease were observed in DSS induced model.


9.jpeg

Th1/Th2/Th17 cell involved in DSS induced chronic colitis model,especially Th17 cell.

TALK WITH OUR EXPERTS

GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.